ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2018
PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients.
Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comprehensive Outcomes for After Cancer Health (COACH): the Feasibility and Impact of an MHealth Augmented Coaching Program for Self-Management in Cancer Survivors
Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Development of depression in patients with oropharyngeal cancer: a systematic review.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026Pooled it
- An HRQOL Proof-Of-Concept Analysis of the eHealth TOGETHER Intervention for Adolescent and Young Adult Cancer Survivors: A Brief Report.Psycho-oncology · 2025Trial
- Who benefits from an eHealth-based stress management intervention in advanced prostate cancer? Results from a randomized controlled trial.Psycho-oncology · 2022Trial
- Losing trust in body sensations: Interoceptive awareness and depression symptom severity among primary care patients.Journal of affective disorders · 2021Trial
- Technology-Based Psychosocial Intervention to Improve Quality of Life and Reduce Symptom Burden in Men with Advanced Prostate Cancer: Results from a Randomized Controlled Trial.International journal of behavioral medicine · 2020Trial
- Use of the Chatbot "Vivibot" to Deliver Positive Psychology Skills and Promote Well-Being Among Young People After Cancer Treatment: Randomized Controlled Feasibility Trial.JMIR mHealth and uHealth · 2019Trial
- Validation of PROMIS emotional distress short form scales for cervical cancer.Gynecologic oncology · 2018Trial
- Normalization of Gastrointestinal Symptoms in Adults With Constipation With Daily Green Kiwifruit Consumption: Protocol for an Open-Label Intervention Study.JMIR research protocols · 2026Article
- Validity of the Arabic Version of the PROMIS Anxiety and PROMIS Depression in Cancer Questionnaires: Measuring Depression and Anxiety in Oncologic Patients in Saudi Arabia-A Rasch Analysis Study.Journal of clinical medicine · 2025Article
- Comparative analysis of pediatric depression measures in clinical sample: evaluation of the PROMIS pediatric depression short form.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025Article
- Rural-Urban Disparities in Cancer Care-Analyzing Routinely Collected Patient-Reported Outcomes. A Cross-Sectional Study.Cancer medicine · 2025Article
- The impact of the COVID-19 pandemic on perceptions of social relationships, negative affect, and paranoid ideation.European archives of psychiatry and clinical neuroscience · 2025Article
- Arabic Translation and Rasch Validation of PROMIS Anxiety Short Form among General Population in Saudi Arabia.Behavioral sciences (Basel, Switzerland) · 2024Article
- The association of diabetes mellitus and routinely collected patient-reported outcomes in patients with cancer. A real-world cohort study.Cancer medicine · 2024Article
- Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies-Results from the CARE registry.Cancer medicine · 2023Article
- Comorbidity burden and health-related quality of life in men with advanced prostate cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Observational
- Comparative analysis of pediatric anxiety measures in clinical sample: evaluation of the PROMIS pediatric anxiety short forms.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023Article
- Two-step screening for depressive symptoms in patients treated with kidney replacement therapies: a cross-sectional analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023Article
- Piloting HealthScore: Feasibility and acceptability of a clinically integrated health coaching program for people living with cancer.Cancer medicine · 2023Article
- Comorbidity burden and health-related quality of life in men with advanced prostate cancer.Research square · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the convergent validity of the Patient-Reported Outcomes Measurement Information System (PROMIS) depression measures relative to legacy measures and criterion validity against a structured diagnostic interview for depression in an oncology sample.
methods132 oncology/haematology outpatients completed the PROMIS Depression Computer Adaptive Test (PROMIS-D-CAT) and PROMIS Depression Short Form (PROMIS-D-SF) along with seven legacy measures: Beck Depression Inventory (BDI); Centre for Epidemiological Studies Depression (CES-D); Depression, Anxiety and Stress Scale; Hospital Anxiety and Depression Scale; Patient Health Questionnaire; Distress Thermometer and PSYCH-6. Correlations, area under the curve (AUC) and diagnostic accuracy statistics were calculated with Structured Clinical Interview as the gold standard.
resultsBoth PROMIS measures correlated with all legacy measures at p < .001 (ρ = 0.589-0.810) and all AUCs (> 0.800) were comparable. At the cut-off points for mild depression of 53, the PROMIS measures had sensitivity (0.83 for PROMIS-D-CAT and 0.80 for PROMIS-D-SF) similar to or better than 6/7 legacy measures with high negative predictive value (> 90%). At cut-off points of 60 for moderate depression, PROMIS measures had specificity > 90%, similar to or better than all legacy measures and positive predictive value ≥ 0.50 (similar to 5/7 legacy measures).
conclusionsThe convergent and criterion validity of the PROMIS depression measures in cancer populations was confirmed, although the optimal cut-off points are not established. PROMIS measures were briefer than BDI-II and CES-D but do not offer any advance in terms of diagnostic accuracy, reduced response burden or cost over other legacy measures of depression in oncology patients.
Indexed as
Identifiers
29423755What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.